Neurocrine Biosciences (NBIX) EBIT (2009 - 2026)
Neurocrine Biosciences (NBIX) recorded EBIT of $331.3 million in Q3 2026, up 38.6% from $239 million a year earlier and up 118.7% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) EBIT (2009 - 2026) Analysis & Trends
On a TTM basis, Neurocrine Biosciences' EBIT came in at $887.1 million as of Sep 30, 2026, up 61.2% year-over-year; for FY2025, it came in at $619.1 million, up 8.5% from FY2024.
- Annual EBIT has increased for four straight years, with a five-year compound annual growth rate of 30.6% (FY2020 to FY2025).
- Across earlier years, EBIT came in at $570.5 million in FY2024 (+127.4%), $250.9 million in FY2023 (+0.8%), $249 million in FY2022 (+142.9%) and $102.5 million in FY2021 (-37.1%).
- The Q3 2026 figure is the highest quarterly EBIT in data going back to Q2 2010.
- On a year-over-year basis, EBIT has increased for six consecutive quarters, with growth averaging 94.9% over the last eight quarters.
- Peak year-over-year performance for EBIT in the last five years was growth of 719.5% in Q1 2026, against a decline of 90.2% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $151.5 million (Q2 2026), $193.4 million (Q1 2026) and $210.9 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.41 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.56 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn | 331.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 331.30 Mn |
| Jun 30, 2026 | 151.50 Mn |
| Mar 31, 2026 | 193.40 Mn |
| Dec 31, 2025 | 210.90 Mn |
| Sep 30, 2025 | 239.00 Mn |
| Jun 30, 2025 | 145.60 Mn |
| Mar 31, 2025 | 23.60 Mn |
| Dec 31, 2024 | 142.00 Mn |
| Sep 30, 2024 | 183.80 Mn |
| Jun 30, 2024 | 145.40 Mn |
| Mar 31, 2024 | 99.30 Mn |
| Dec 31, 2023 | 150.30 Mn |
| Sep 30, 2023 | 141.20 Mn |
| Jun 30, 2023 | 73.60 Mn |
| Mar 31, 2023 | -114.20 Mn |
| Dec 31, 2022 | 103.40 Mn |
| Sep 30, 2022 | 87.80 Mn |
| Jun 30, 2022 | 54.70 Mn |
| Mar 31, 2022 | 3.10 Mn |
| Dec 31, 2021 | -36.30 Mn |
API Access
Neurocrine Biosciences EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();